Hyperpolarized Xenon functional MRI of human lungs

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$121,588.00
Award Year:
2006
Program:
STTR
Phase:
Phase I
Contract:
1R41HL082013-01A1
Award Id:
80329
Agency Tracking Number:
HL082013
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
XEMED, LLC, 16 Strafford Avenue, DURHAM, NH, 03824
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
FARHODNOZIROV
(603) 862-3512
farhod1970@gmail.com
Business Contact:
HERSMAN
(603) 868-1888
HERSMAN@UNH.EDU
Research Institute:
BRIGHAM AND WOMEN'S HOSPITAL

BRIGHAM AND WOMEN'S HOSPITAL
RESEARCH ADMINISTRATION
BOSTON, MA, 02115

Domestic nonprofit research organization
Abstract
DESCRIPTION (provided by applicant): While obstructive lung disease is the fourth leading cause of death in the US, high-resolution non-invasive functional assessment of lungs is lagging behind imaging of other vital organs. Emphysema is characterized by a sudden irreversible decay of lung tissue, reducing the surface area for gas exchange while increasing the alveolar void dimensions. MRI diffusion-weighted sequences with hyperpolarized gases measure diffusion distance versus time, probing the void spatial dimensions. Although 3He diffusion MRI exposes emphysema's ravaging effects in mid and late stages, the fast diffusion of 3He (atoms travel normal alveolar diameters in less than a millisecond) interferes with early diagnosis and quantitative tracking of the disease. The lower diffusion constant of xenon offers sensitivity to restrictions to diffusion that are a factor of 3.7 smaller (along one dimension) than those probed with 3He, allowing detection of early emphysema when alveolar volumes are a factor of fifty smaller. Furthermore, the solubility of xenon in lung surface tissues offers a second, complementary measure of lung microstructure. Unlike 3He which is expensive, not found in nature, and only occurs as a byproduct of weapons development, xenon is cheap and abundant and therefore commercially viable. The primary obstacle to exploiting these advantages, low polarization using routine production techniques, has now been overcome. The new conter-flowing polarizer developed at UNH and Xemed offers a factor often higher magnetization output than the best competing designs. We will demonstrate that hyperpolarized xenon-129 MRI exceeds the sensitivity of 3He to early emphysema by performing the following measurements in healthy human subjects: 1. We will determine alveolar dimensions by measuring average diffusion distance as a function of time 2. We will measure local alveolar surface-to-volume ratio using xenon polarization transfer between the gas space (volume) and the xenon dissolved in the lung tissue (surface). Through multiple measurements under identical conditions, we will determine the internal consistency, reproducibility, and sensitivity to changes of these measurements. Demonstration of quantitative properties of this protocol could lead to new research into triggers for emphysema and therapeutics for slowing its progress, resulting in commercialization opportunities.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government